Status:

COMPLETED

Randomized Comparison of ExoSeal® and Angio-Seal Vascular Closure Devices: The CLOSE-UP II Trial

Lead Sponsor:

Aarhus University Hospital Skejby

Collaborating Sponsors:

Cordis US Corp.

Abbott Medical Devices

Conditions:

Coronary Disease

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Is the ExoSeal VSD non-inferior to Angio-Seal vascular closure device (VSD) in the incidence of adverse access site related events at 30 days.

Detailed Description

Prospective, randomized (1:1) controlled, single blind, single center study in 2000 percutaneous coronary intervention (PCI) patients comparing the ExoSeal VCD (test device) to the AngioSeal VCD (stan...

Eligibility Criteria

Inclusion

  • Should be able to provide valid informed signed consent
  • PCI procedure including treatment by balloon and/or stent
  • PCI indicated by silent ischemia, stable angina pectoris, non-ST elevation myocardial infarction (NSTEMI) or ST elevation myocardial infarction (STEMI)

Exclusion

  • Only coronary angiography
  • Multiple punctures
  • Active infection
  • Groin haematoma before the closure procedure
  • Sheath size \> 7 French
  • Known pseudoaneurysm or arteriovenous (AV)-fistula in the ipsilateral groin
  • Prior arterial surgery in abdomen and/or lower extremities
  • Cardiogenic shock
  • Life expectancy less than one year
  • The patient is a female of childbearing potential with possible pregnancy or a positive pregnancy test within 7 days before the index procedure or is lactating
  • Simultaneous or planned subsequent femoral vein access
  • Allergy to any of the components in the closure material left in the groin
  • Puncture on same site \< 30 days
  • Peripheral artery disease patients can be included at operator´s discretion except if heavy calcification is present at the access site which at the operator's discretion precludes insertion of the VCD

Key Trial Info

Start Date :

December 21 2012

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 14 2017

Estimated Enrollment :

818 Patients enrolled

Trial Details

Trial ID

NCT02234830

Start Date

December 21 2012

End Date

May 14 2017

Last Update

June 1 2017

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Aarhus University Hospital

Aarhus N, Denmark, 8200

2

Odense University Hospital

Odense, Denmark, 5000